ArticleFrontiers in immunology2022

Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection.

Enrico Munari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.